7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6h)-one has been researched along with Colonic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aga, MA; Ali, S; Behl, A; Hamid, A; Hussain, A; Khan, S; Mondhe, DM; Qazi, AK; Saxena, AK; Shah, BA; Singh, SK; Taneja, SC | 1 |
1 other study(ies) available for 7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6h)-one and Colonic Neoplasms
| Article | Year |
|---|---|
Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Ehrlich Tumor; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Class Ia Phosphatidylinositol 3-Kinase; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Design; Female; Forkhead Box Protein O3; Forkhead Transcription Factors; G1 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; Male; Membrane Potential, Mitochondrial; Mice; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; RNA Interference; Signal Transduction; Time Factors; Transfection; Tumor Burden | 2015 |